AUA, others comment on new USPSTF draft on screening for risk of prostate cancer

The American Urological Association (AUA), along with other organizations, issued a statement yesterday regarding their reactions to the new, draft guidance issues by the U.S. Preventive Services Task Force (USPSTF). … READ MORE …

New draft USPSTF guidance on screening for risk of prostate cancer (the details)

As indicated earlier this morning, the US Preventive Services Task Force (USPSTF) has issued new draft guidance on screening for risk of prostate cancer. Access to all the relevant details is provided below: … READ MORE …

USPSTF changes guidance on testing for risk of prostate cancer

As yet we have not seen the details, but, according to a report on National Public Radio early this morning, the US Preventive Services Task Force (USPSTF) has stated that men up to age 70 should discuss the risk and benefits of PSA testing with their doctors and then make individual decisions about whether to get tested. … READ MORE …

MRI as a means of screening for prostate cancer? Probably not!

A report on the HealthDay web site related to a presentation about the role of MRI scanning in the diagnosis of localized prostate cancer seems to demonstrate a significant division of views about the value of standardized use of mpMRI in the diagnosis of prostate cancer. … READ MORE …

USPSTF selects AUA-nominated urologist to review evidence report on prostate cancer screening

As many readers will be aware, the U.S. Preventive Services Task Force (USPSTF) is in process of developing a new “evidence report” which will form the basis of any update to current USPSTF recommendations about prostate cancer screening. … READ MORE …

Starting the new year with two of the usual controversies

Strictly speaking, JAMA Oncology actually ended the old year (in its issue on December 29, 2016), rather than beginning the new one, with two articles, a letter to the editor, and an editorial that deal with two of the more controversial issues that affect the way we think about the management of prostate cancer. … READ MORE …

And now … data from the PCLO trial at 15 years …

A new update on the prostate cancer outcomes of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial has given us a rather different interpretation of the meaning of the data from this trial — although whether that “meaning” actually has “meaning” is probably up for debate. … READ MORE …